PerkinElmer hosts Revolutionaries for Global Health Summit in Brussels
1 March 2013 | By Edelman (On behalf of PerkinElmer)
Revolutionaries for Global Health Summit, 5 -6 March 2013, Brussels...
List view / Grid view
News
Bruce Kuhlik and Merck Honored by PBI for commitment to pro bono
28 February 2013 | By Merck
Merck announces that the Pro Bono Institute (PBI) has selected Executive Vice President Bruce Kuhlik as the winner...
ViiV Healthcare announces a voluntary licence agreement with the Medicines Patent Pool to increase access to HIV medicines for children
28 February 2013 | By
Agreement brings the number of voluntary...
Boehringer Ingelheim announces initiation of pivotal trial investigating volasertib* in patients with acute myeloid leukaemia
28 February 2013 | By Boehringer Ingelheim
Boehringer Ingelheim invests in rare diseases...
Novartis collaboration aims to eliminate rheumatic heart disease (RHD) in Zambia
28 February 2013 | By Novartis
Novartis today announced that it has launched an effort to eliminate rheumatic heart disease in Zambia in collaboration with the Lusaka...
EURORDIS awards Celgene Corporation for excellence in medical innovation in rare diseases
27 February 2013 | By Weber Shandwick
EURORDIS announced that Celgene Corporation has been awarded the prestigious EURORDIS Company Award for excellence in the field of rare diseases...
Genzyme receives company award from European Organisation for Rare Diseases
27 February 2013 | By Genzyme
Sanofi and its subsidiary Genzyme announced today that Genzyme has received a Company Award from EURORDIS...
Join Lonza’s March webinar on endotoxin detection methods
There are many Limulus Amebocyte Lysate (LAL) methods commercially available today. Hence, Lonza is hosting a free, 60-minute webinar entitled "Endotoxin Detection – Which Method Is Best for Me" at two different dates and times.
Academy and Alzheimer’s Drug Discovery Foundation award challenge grant for research of biomarkers in Alzheimer’s disease
26 February 2013 | By The New York Academy of Sciences
The Academy awarded a challenge grant...
Roche launches new process for accessing clinical trial data
26 February 2013 | By Roche
Independent body to grant access to patient-level data for scientific review...
AstraZeneca announces results from long-term safety trial of naloxegol in patients with opioid-induced constipation
26 February 2013 | By AstraZeneca
AstraZeneca announced high-level results from KODIAC-08...
Novartis reports Phase III data showing omalizumab improved itch in patients with a chronic form of hives who failed standard therapy[1]
24 February 2013 | By Novartis
Late-breaking results from ASTERIA II...
Phase III results: tiotropium* Respimat® is effective in symptomatic asthma patients irrespective of their allergic status
23 February 2013 | By Boehringer Ingelheim
New Phase III data presented...
European Medicines Agency recommends approval of Hexyon/Hexacima 6-in-1 pediatric vaccine
22 February 2013 | By Sanofi
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine...
FDA approves Roche’s Kadcyla (trastuzumab emtansine)
22 February 2013 | By Roche
New personalised medicine helped people in Phase III study live longer, compared to standard treatment...
